All lobbying filings

SIEMENS MEDICAL SOLUTIONS USA, INC

Lobbying for SIEMENS MEDICAL SOLUTIONS USA, INC

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $590,000.00 expenses · posted Apr 21, 2025

Official filing document

Bills named in this filing 5

HR 2120
ROCR Value Based Program Act
S 1031
ROCR Value Based Program Act
S 1399
Health Tech Investment Act
HR 1968
Full-Year Continuing Appropriations and Extensions Act, 2025
HR 2381
SCREENS for Cancer Act of 2025

Lobbying activity 6

Medicare/Medicaid

H.R. 2120 / S. 1031 - Radiation Oncology Case Rate Value Based Program Act; and S. 1399 - Health Tech Investment Act. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.

Budget/Appropriations

Public Law 119 / H.R. 1968 - Full year Continuing Appropriations and Extensions Act.

Taxation/Internal Revenue Code

Public Law 115-97 (Tax Cut and Jobs Act) - issues related to expiring tax provisions.

Trade (domestic/foreign)

Issues related to availability of medical isotopes; Issues related to medical supply chains and procurement; and Issues related to international trade.

Tariff (miscellaneous tariff bills)

Issues related to tariffs and supply chain resilience.

Health Issues

H.R. 2381 -- SCREENS for Cancer Act of 2025. Issues related to FDA & third-party regulation of AI and Machine Learning-enabled devices, and potential future frameworks for generative AI; Issues related to Artificial Intelligence for medical devices; and Issues related to right to repair.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.